A role for natural killer T cells in asthma

Nature Reviews Immunology

Volumn 6, Issue 12, 2006, Pages 953-958

  Umetsu, Dale T ^a,b   Dekruyff, Rosemarie H ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; ANTIASTHMATIC AGENT; CD1D ANTIBODY; CORTICOSTEROID; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ANTIGEN EXPRESSION; ASTHMA; AUTOIMMUNITY; BASOPHIL; CELL FUNCTION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; DRUG EFFICACY; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; IMMUNOSTIMULATION; INFLAMMATION; MAST CELL; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME;

ANIMALS; ASTHMA; HUMANS; KILLER CELLS, NATURAL; MICE; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS;

EID: 33845211133     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1968     Document Type: Review

References (58)

1. + T-cells in asthma. Eur. Respir. J. 18, 45-52 (2001).
2. + T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am. J. Respir. Cell Mol. Biol. 10, 587-593 (1994).
3. Azzawi, M. et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am. Rev. Respir. Dis. 142, 1407-1413 (1990).
4. H2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326, 298-304 (1992).
5. H2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Invest. 103, 175-183 (1999).
6. H2 cells in a mouse model of asthma. J. Immunol. 162, 2375-2383 (1999).
7. H1, cells. J. Immunol. 161, 3813-3816 (1998).
8. Corry, D. B. et al. Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol. Med. 4, 344-355 (1998).
9. Godfrey, D. I. & Kronenberg, M. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114, 1379-1388 (2004).
10. Taniguchi, M., Harada, M., Kojo, S., Nakayama, T. & Wakao, H. The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21, 483-513 (2003).
11. Exley, M. A. & Koziel, M. J. To be or not to be NKT: natural killer T cells in the liver. Hepatology 40, 1033-1040 (2004).
12. Seino, K. & Taniguchi, M. Functionally distinct NKT cell subsets and subtypes. J. Exp. Med. 202, 1623-1626 (2005).
13. H2 response in ulcerative colitis. J. Clin. Invest. 113, 1490-1497 (2004).
14. Terabe, M. et al. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nature Immunol. 1, 515-520 (2000).
15. Akbari, O. et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nature Med. 9, 582-588(2003).
16. Lisbonne, M. et al. Invariant Vα14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 171, 1637-1641 (2003).
17. Brigl, M. & Brenner, M. B. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22, 817-890 (2004).
18. Kinjo, Y. et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434, 520-525 (2005).
19. Zhou, D. P. et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306, 1786-1789 (2004).
20. Kronenberg, M. & Rudensky, A. Regulation of immunity by self-reactive T cells. Nature 435, 598-604 (2005).
21. H1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature 391, 177-181 (1998).
22. Kinjo, Y. et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nature Immunol. 7, 978-986 (2006).
23. Crowe, N. Y. et al. Differential antitumor immunity mediated by NKT cell subsets in vivo. J. Exp. Med. 202, 1279-1288 (2005).
24. Lowsky, R. et al. Protective conditioning for acute graft-versus-host disease. N. Engl. J. Med. 353, 1321-1331 (2005).
25. H1-type immune responses exacerbating lupus. J. Clin. Invest. 112, 1211-1222 (2003).
26. Bilenki, L., Yang, J., Fan, Y., Wang, S. & Yang, X. Natural killer T cells contribute to airway eosinophilic inflammation induced by ragweed through enhanced IL-4 and eotaxin production. Eur. J. Immunol. 34, 345-354 (2004).
27. Cui, J. et al. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer T cells. J. Exp. Med. 190, 783-792 (1999).
28. Smiley, S. T., Kaplan, M. H. & Grusby, M. J. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 275, 977-979 (1997).
29. + T cells that promptly produce interleukin 4. Proc. Natl Acad. Sci. USA 92, 11931-11934 (1995).
30. Kim, J. O. et al. Asthma is induced by intranasal coadministration of allergen and natural killer T-cell ligand in a mouse model. J. Allergy Clin. Immunol. 114, 1332-1338 (2004).
31. + T cells. Proc. Natl Acad. Sci. USA 103, 2782-2787 (2006).
32. Bendelac, A., Hunziker, R. D. & Lantz, O. Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells. J. Exp. Med. 184, 1285-1293 (1996).
33. H2 response and in immunoglobulin E production. Science 270, 1845-1847 (1995).
34. Galli, G. et al. Innate immune responses support adaptive immunity: NKT cells induce B cell activation. Vaccine 21 (Suppl. 2), 48-54 (2003).
35. Korsgren, M. et al. Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J. Exp. Med. 189, 553-562 (1999).
36. + T cells are not essential for T helper cell 2 immune responses. J. Exp. Med. 184, 1295-1304 (1996).
37. 2- Microglobulin-dependent T cells are dispensable for allergen-induced T helper 2 responses. J. Exp. Med. 184, 1507-1512 (1996).
38. 2-microglobulin-dependent and independent forms. J. Immunol. 161, 1710-1717 (1998).
39. 2-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells. J. Immunol. 172, 6115-6122 (2004).
40. 2-microglobulin. J. Biol. Chem. 274, 9289-9295 (1999).
41. Townsend, M. J. et al. T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells. Immunity 20, 477-494 (2004).
42. Finotto, S. et al. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 295, 336-338 (2002).
43. Benlagha, K., Kyin, T., Beavis, A., Teyton, L. & Bendelac, A. A thymic precursor to the NK T cell lineage. Science 296, 553-555 (2002).
44. + natural killer T cells in bronchial asthma. N. Engl. J. Med. 354, 1117-1129 (2006).
45. Ikegami, Y., Yokoyama, A., Haruta, Y., Hiyama, K. & Kohno, N. Circulating natural killer T cells in patients with asthma. J. Asthma 41, 877-882 (2004).
46. Gumperz, J. E., Miyake, S., Yamamura, T. & Brenner, M. B. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195, 625-636 (2002).
47. Lee, P. T., Benlagha, K., Teyton, L. & Bendelac, A. Distinct functional lineages of human Vα24 natural killer T cells. J. Exp. Med. 195, 637-641 (2002).
48. Johnston, B., Kim, C., Soler, D., Emoto, M. & Butcher, E. Differential chemokine responses and homing patterns of murine TCRαβ NKT cell subsets. J. Immunol. 171, 2960-2969 (2003).
49. Mattner, J. et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434, 525-529 (2005).
50. Agea, E. et al. Human CD1-restricted T cell recognition of lipids from pollens. J. Exp. Med. 202, 295-308 (2005).
51. Adcock, I. M. & Ito, K. Steroid resistance in asthma: a major problem requiring novel solutions or a nonissue? Curr. Opin. Pharmacol. 4, 257-262 (2004).
52. Ito, K., Chung, K. F. & Adcock, I. M. Update on glucocorticoid action and resistance. J. Allergy Clin. Immunol. 117, 522-543 (2006).
53. + T cells to dexamethasone. J. Immunol. 163, 2522-2529 (1999).
54. H2 balance. J. Immunol. 161, 1239-1247 (1998).
55. Hachem, P. et al. α-Galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: role of IFN-γ. Eur. J. Immunol. 35, 2793-2802 (2005).
56. Matsuda, H. et al. α-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation. Am. J. Respir. Cell Mol. Biol. 33, 22-31 (2005).
57. Morishima, Y. et al. Suppression of eosinophilic airway inflammation by treatment with α-galactosylceramide. Eur. J. Immunol. 35, 2803-2814 (2005).
58. Parekh, V. V. et al. Glycolipid antigen induces long-term natural killer T cell anergy in mice. J. Clin. Invest. 115, 2572-2583 (2005).